Venturi Wealth Management LLC Purchases 1,305 Shares of Amdocs Limited (NASDAQ:DOX)

Venturi Wealth Management LLC raised its position in Amdocs Limited (NASDAQ:DOXFree Report) by 12.5% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 11,725 shares of the technology company’s stock after purchasing an additional 1,305 shares during the period. Venturi Wealth Management LLC’s holdings in Amdocs were worth $1,026,000 as of its most recent filing with the SEC.

Several other large investors have also recently bought and sold shares of DOX. Catalyst Capital Advisors LLC acquired a new position in shares of Amdocs in the third quarter valued at approximately $55,000. GAMMA Investing LLC grew its stake in Amdocs by 115.1% during the third quarter. GAMMA Investing LLC now owns 800 shares of the technology company’s stock worth $70,000 after buying an additional 428 shares in the last quarter. American National Bank acquired a new stake in Amdocs during the second quarter worth about $76,000. Blue Trust Inc. boosted its stake in shares of Amdocs by 18.0% in the 2nd quarter. Blue Trust Inc. now owns 1,138 shares of the technology company’s stock valued at $90,000 after purchasing an additional 174 shares in the last quarter. Finally, Asset Management One Co. Ltd. boosted its stake in shares of Amdocs by 37.9% in the 3rd quarter. Asset Management One Co. Ltd. now owns 2,175 shares of the technology company’s stock valued at $190,000 after purchasing an additional 598 shares in the last quarter. Institutional investors own 92.02% of the company’s stock.

Amdocs Trading Up 0.7 %

Shares of Amdocs stock opened at $92.86 on Tuesday. Amdocs Limited has a 52-week low of $74.41 and a 52-week high of $94.04. The stock’s 50-day simple moving average is $87.92 and its 200 day simple moving average is $83.81. The stock has a market capitalization of $10.91 billion, a P/E ratio of 21.40, a P/E/G ratio of 1.49 and a beta of 0.74. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.24 and a current ratio of 1.24.

Analyst Upgrades and Downgrades

Several research firms recently commented on DOX. Stifel Nicolaus began coverage on shares of Amdocs in a research report on Wednesday, October 2nd. They set a “buy” rating and a $100.00 target price on the stock. StockNews.com upgraded shares of Amdocs from a “buy” rating to a “strong-buy” rating in a research note on Friday, October 25th. One equities research analyst has rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, Amdocs presently has an average rating of “Buy” and an average price target of $102.00.

View Our Latest Research Report on Amdocs

Amdocs Company Profile

(Free Report)

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.

See Also

Want to see what other hedge funds are holding DOX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amdocs Limited (NASDAQ:DOXFree Report).

Institutional Ownership by Quarter for Amdocs (NASDAQ:DOX)

Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.